Digest Réseau Comment ça marche
Réseau
/
Sociétés
Pr
Non vérifié

ProMIS Neurosciences Inc.

Ce que nous écrivons

Annonces ÉconomiquesBiotechnologiePhotographiePublicité/Marketing/Médias/Communication

18 communiqués de presse

Voir tous les communiqués de presse
13/08/2026
Biotechnologie
Annonces Économiques
Publicité/Marketing/Médias/Communication
ProMIS Neurosciences Announces Second Quarter 2026 Financial Results and Provides Corporate Highlights
Source
ProMIS Neurosciences Inc.
Émetteur
GLOBENEWSWIRE
1.00
0
28/07/2026
Biotechnologie
Annonces Économiques
Publicité/Marketing/Médias/Communication
ProMIS Neurosciences Reports Positive Blinded Six-Month Interim Safety and Biomarker Data for PMN310 in the PRECISE-AD Phase 1b Alzheimer’s Disease Trial
Source
ProMIS Neurosciences Inc.
Émetteur
GLOBENEWSWIRE
1.00
0
27/07/2026
Biotechnologie
Annonces Économiques
Publicité/Marketing/Médias/Communication
ProMIS Neurosciences to Host Webinar to Discuss Upcoming 6-Month Blinded Interim Data from PRECISE-AD Phase 1b Trial of PMN310 in Alzheimer’s Disease
Source
ProMIS Neurosciences Inc.
Émetteur
GLOBENEWSWIRE
1.00
0
13/07/2026
Biotechnologie
Annonces Économiques
Publicité/Marketing/Médias/Communication
ProMIS Neurosciences Reports First Human Evidence of Amyloid-Beta Oligomer Target Engagement by PMN310 at AAIC 2026
Source
ProMIS Neurosciences Inc.
Émetteur
GLOBENEWSWIRE
1.00
0
12/05/2026
Biotechnologie
Annonces Économiques
Publicité/Marketing/Médias/Communication
ProMIS Neurosciences Announces First Quarter 2026 Financial Results and Provides Corporate Highlights
Source
ProMIS Neurosciences Inc.
Émetteur
GLOBENEWSWIRE
1.00
0
25/03/2026
Biotechnologie
Annonces Économiques
Publicité/Marketing/Médias/Communication
ProMIS Neurosciences Announces Full Year 2025 Financial Results and Provides Corporate Highlights
Source
ProMIS Neurosciences Inc.
Émetteur
GLOBENEWSWIRE
1.00
0
18/03/2026
Biotechnologie
Annonces Économiques
Publicité/Marketing/Médias/Communication
ProMIS Neurosciences to Present Data on ALS & Parkinsons Disease Programs at Alzheimer’s Disease/Parkinson’s Disease 2026 International Conference (AD/PD™)
Source
ProMIS Neurosciences Inc.
Émetteur
GLOBENEWSWIRE
1.00
0
04/02/2026
Biotechnologie
Annonces Économiques
Publicité/Marketing/Médias/Communication
ProMIS Neurosciences to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026
Source
ProMIS Neurosciences Inc.
Émetteur
GLOBENEWSWIRE
1.00
0
30/01/2026
Biotechnologie
Annonces Économiques
Publicité/Marketing/Médias/Communication
ProMIS Neurosciences Announces Up to $175 Million Private Placement Financing
Source
ProMIS Neurosciences Inc.
Émetteur
GLOBENEWSWIRE
1.00
0
18/12/2025
Biotechnologie
Annonces Économiques
ProMIS Neurosciences Exceeds Target Enrollment in PRECISE-AD Phase 1b Clinical Trial of PMN310 in Alzheimer’s Disease
Source
ProMIS Neurosciences Inc.
Émetteur
GLOBENEWSWIRE
1.00
0

Détails du contact

Réseaux sociaux

Followers
0
Compatibilité
0